Prestige Consumer Healthcare, Inc. engages in the marketing, sale, and distribution of pharmaceutical drugs and consumer products. The company is headquartered in Tarrytown, New York and currently employs 600 full-time employees. The company went IPO on 2005-02-10. The firm is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club stores and e-commerce channels in North America (the United States and Canada) and in Australia and certain other international markets. Its segments include North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands includes Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart removal products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment products, Debrox earwax remover, and others.
¿Cuál es el ratio P/E de Prestige Consumer Healthcare Inc (PBH)?
El ratio P/E de Prestige Consumer Healthcare Inc es 13.7124
¿Quién es el CEO de Prestige Consumer Healthcare Inc?
Mr. Ronald Lombardi es el Chairman of the Board de Prestige Consumer Healthcare Inc, se unió a la empresa desde 2010.
¿Qué tal es el rendimiento del precio de la acción PBH?
El precio actual de PBH es de $52.42, ha 下降 un 0.11% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Prestige Consumer Healthcare Inc?
Prestige Consumer Healthcare Inc pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Prestige Consumer Healthcare Inc?
La capitalización bursátil actual de Prestige Consumer Healthcare Inc es $2.4B
¿Es Prestige Consumer Healthcare Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 6 analistas han realizado calificaciones de análisis para Prestige Consumer Healthcare Inc, incluyendo 3 fuerte compra, 3 compra, 4 mantener, 0 venta, y 3 fuerte venta